[go: up one dir, main page]

HK1247845A1 - 用於在人和動物中處理"斑和纏結"的組合物和方法 - Google Patents

用於在人和動物中處理"斑和纏結"的組合物和方法

Info

Publication number
HK1247845A1
HK1247845A1 HK18107417.0A HK18107417A HK1247845A1 HK 1247845 A1 HK1247845 A1 HK 1247845A1 HK 18107417 A HK18107417 A HK 18107417A HK 1247845 A1 HK1247845 A1 HK 1247845A1
Authority
HK
Hong Kong
Prior art keywords
tangles
plaques
humans
animals
compositions
Prior art date
Application number
HK18107417.0A
Other languages
English (en)
Inventor
Judy Cam
Thomas Lake
Qubai Hu
Joel Cummings
Alan D Snow
Original Assignee
Cognitive Clarity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognitive Clarity Inc filed Critical Cognitive Clarity Inc
Publication of HK1247845A1 publication Critical patent/HK1247845A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18107417.0A 2015-02-27 2018-06-07 用於在人和動物中處理"斑和纏結"的組合物和方法 HK1247845A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562126026P 2015-02-27 2015-02-27
US201562170822P 2015-06-04 2015-06-04
PCT/US2016/019572 WO2016138270A2 (en) 2015-02-27 2016-02-25 Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Publications (1)

Publication Number Publication Date
HK1247845A1 true HK1247845A1 (zh) 2018-10-05

Family

ID=56789214

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107417.0A HK1247845A1 (zh) 2015-02-27 2018-06-07 用於在人和動物中處理"斑和纏結"的組合物和方法

Country Status (10)

Country Link
US (3) US10307454B2 (zh)
EP (1) EP3261655A4 (zh)
JP (1) JP6796072B2 (zh)
CN (1) CN107530389B (zh)
AU (1) AU2016222650B2 (zh)
CA (1) CA3015127C (zh)
HK (1) HK1247845A1 (zh)
MX (1) MX381186B (zh)
SG (1) SG11201706861QA (zh)
WO (1) WO2016138270A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107530389B (zh) 2015-02-27 2021-10-26 考格尼克拉瑞提公司 用于在人和动物中处理“斑和缠结”的组合物和方法
SG11202106222YA (en) 2018-12-12 2021-07-29 Cognitive Clarity Inc Compositions and methods for the treatment of "plaques and tangles" in humans and animals
US11883457B1 (en) 2022-09-06 2024-01-30 Optigenex Inc. Method of enhancing cognition in individuals with at least normal cognition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
US6264994B1 (en) * 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
AU7580098A (en) 1997-05-15 1998-12-08 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
US6346280B1 (en) 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
JP4537577B2 (ja) 1998-03-13 2010-09-01 ユニバーシティ・オブ・ワシントン アルツハイマー病及びプリオン病の治療に関する抗プラーク療法を特定するコンゴ好染性マルタ十字形アミロイドプラークのｉｎｖｉｔｒｏにおける形成
JP2003171298A (ja) * 2001-12-11 2003-06-17 Nonogawa Shoji Kk 抗アレルギー剤
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070190075A1 (en) 2003-10-09 2007-08-16 Advangen, Inc. C/O National Institute Of Advance Science And Tech Hair growth stimulant composition
JP4321769B2 (ja) * 2004-04-13 2009-08-26 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物
JP4954552B2 (ja) * 2006-01-07 2012-06-20 日本メナード化粧品株式会社 抗アレルギー剤
JP2007230977A (ja) * 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd 顆粒球・マクロファージコロニー刺激因子（ｇｍ−ｃｓｆ）産生抑制剤ｉｉ
JP2007277163A (ja) * 2006-04-06 2007-10-25 Uha Mikakuto Co Ltd ジペプチジルペプチダーゼｉｖ阻害剤
TW200812637A (en) * 2006-09-15 2008-03-16 jun-er Wang Vegetable composition for cleaning oral cavity
JP2010013423A (ja) * 2008-07-07 2010-01-21 Lion Corp ジペプチジルペプチダーゼ−ｉｖ阻害剤
JP5688606B2 (ja) 2012-02-17 2015-03-25 株式会社シェフコ 機能性原料を含有する水素含有飲料の製造方法
CN107530389B (zh) * 2015-02-27 2021-10-26 考格尼克拉瑞提公司 用于在人和动物中处理“斑和缠结”的组合物和方法

Also Published As

Publication number Publication date
WO2016138270A2 (en) 2016-09-01
US11376300B2 (en) 2022-07-05
US10350258B2 (en) 2019-07-16
MX2017010873A (es) 2018-11-12
CN107530389A (zh) 2018-01-02
MX381186B (es) 2025-03-12
WO2016138270A3 (en) 2016-10-27
JP2018513838A (ja) 2018-05-31
US20190240279A9 (en) 2019-08-08
US20160250273A1 (en) 2016-09-01
AU2016222650B2 (en) 2021-11-04
CA3015127C (en) 2023-10-10
JP6796072B2 (ja) 2020-12-02
CA3015127A1 (en) 2016-09-01
US10307454B2 (en) 2019-06-04
EP3261655A2 (en) 2018-01-03
US20170333512A1 (en) 2017-11-23
US20190350996A1 (en) 2019-11-21
CN107530389B (zh) 2021-10-26
EP3261655A4 (en) 2018-10-10
AU2016222650A1 (en) 2017-09-07
SG11201706861QA (en) 2017-09-28

Similar Documents

Publication Publication Date Title
IL268406A (en) Preparations and methods for treating hemoglobin diseases
IL260257A (en) Preparations and methods for the treatment of hemoglobinopathies
IL298689B1 (en) Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions
RS65319B1 (sr) 8-cijano-5-piperidino-hinolini kao tlr7/8 antagonisti i njihova upotreba u lečenju imunoloških poremećaja
IL290150A (en) Compounds and methods for treating chronic pain
HK1253769A1 (zh) 用於診斷和治療腎上腺腦白質營養不良的方法和組合物
IL260352B (en) Methods and preparations for the treatment of neurological disease
IL266047A (en) Methods and preparations for the treatment of Fabry disease
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
IL254194A0 (en) Combinations and fixed dose formulations containing etc1002 and ezetimibe and methods for treating or reducing the risk of cardiovascular diseases
HK1258073A1 (zh) 治療細胞質糖原貯積失調的方法和組合物
HK1247845A1 (zh) 用於在人和動物中處理"斑和纏結"的組合物和方法
SG11201705524SA (en) Compositions and methods for the treatment of inflammation and pain
LT3373922T (lt) Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
GB201621737D0 (en) Compositions and methods of treatment
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
ZA201706985B (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
IL265911A (en) Epilimod preparations and methods of using them in the treatment of Alzheimer's disease
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
IL246608A0 (en) Preparations and methods for treating heart disease
SG11202106222YA (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
ZA202004110B (en) Compositions and methods for the treatment of metabolic conditions
IL243402A0 (en) Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases
GB201508518D0 (en) Hair treatment compositions and methods